Home
 

IUIS Newsletter

IUIS Course Material

Official IUIS Journal

The #1 most cited and #1 largest open-access journal in immunology

IUIS at a glance

Inside Immunity

FAIS Legacy Project

IUIS-Sponsored Stipends – Apply Now!

The IUIS Gender Equality and Career Development Committee (GEC) in collaboration with the Federation of Clinical Immunology Societies (FOCIS) will co-sponsor 4 trainees from the developing world to attend an Advanced Course in Basic & Clinical Immunology, in the period between March 3 - 6, 2019, in Estancia La Jolla Resort & Spa La Jolla, USA. IUIS will pay for a travel bursary of up to USD 2,000 maximum, while FOCIS will cover for registration, 4 night’s accommodation and meals during the course. Additional expenses, if any will be the responsibility of the selected participant.

 

Application deadline: Friday, November 30, 2018.

Notification of awards: Friday, December 28, 2018.

 

Click here to read more on this course.

 

The German Society for Immunology (DGfI) is pleased to announce that – through joint sponsorship together with IUIS - 3 full scholarships will be offered for the 15th Spring School on Immunology, March 10th – March 15th 2019 Ettal, Bavaria, Germany, for applicants from developing countries who are studying/working in these countries.

The stipend covers: Travel costs of up to 1.100 EUR (covered by the IUIS).  Registration and accommodation for the duration of the school (covered by the DGfI). Any other expenses will be the responsibility of the student.

 

Application: You will find the online application link on this web page: https://dgfi.org/iuis-dgfi-stipends/ . Applications should be submitted before October 31, 2018.


Read more about the requirements here.

 
Apply for the 2019 Michelson Prizes

 

The Human Vaccines Project is pleased to announce the launch of the 2019 Michelson Prizes. The Michelson Prizes are scientific awards of $150,000 given annually to investigators under age 35 who are applying disruptive research concepts to advance the development of vaccines and immunotherapies for major global diseases.
The 2019 Michelson Prizes have been expanded to include three focus areas:

• Human Immunology
• Computational Biology and Protein Engineering
• Neglected Parasitic Diseases
Applications are now being accepted. The deadline to apply is October 29, 2018.
Read more...
 
Two Immunologists Win 2018 Nobel Prize!

 

IUIS congratulates James Allison and Tasuku Honjo on their Nobel Prize in Physiology or Medicine in 2018 "for their discovery of cancer therapy by inhibition of negative immune regulation." The prize recognises the fundamental immunology research that led to the introduction of immune checkpoint inhibitors for cancer treatment.

Click here to read more.

 
IUIS 2019 at ECI 2018

 

The IUIS 2019 team was in Amsterdam attending ECI 2018 to promote IUIS's international congress, which will take place Oct. 19-23, 2019 in Beijing.

Click here for more information.

 

Read more...
 
Congratulations to Christian T. Mayer!

We have a winner!

The IUIS, together with Vaccines Europe is pleased to announce the 2018 winner of the Early Career Research Prize in Vaccinology R&D. The winner has been identified by a jury of 8 members of the IUIS Vaccine Committee among the excellent applications received from 12 different European countries. According to the standardized scoring system followed, the highest scores were given to Christian T. Mayer (Germany), currently working at Twincore, Center for Experimental and Clinical Infection Research (lab of Prof. Tim Sparwasser), Hannover, Germany.

The IUIS President accompanied by the VAC Chairperson and a VE Representative will present Prize certificates to the winners of the 2017 and 2018 Prizes during an Award Ceremony organized within the broad program of the IUIS European meeting (European Congress of Immunology - ECI 2018) scheduled in September 2018. During the Award Ceremony, the winners are invited to present their research topics in form of a short lecture (15-20 minutes) at the end of the IUIS vaccinology session.

 
Changes to the IUIS Legal Notice and Private Policy

On May 25, 2018, we are updating our Legal Notice and Private Policy to ensure our privacy guidelines keep step with best practices. We encourage you to read them carefully.  Using our website after that date will indicate your agreement to be bound by the new Legal Notice and Private Policy.

Here are the key updates:

  • Easier to read and navigate: we have reorganized the 2 documents, making it easier to understand IUIS’s relationship with its members and website users
  • GDPR compliance: You can, at any time, request the following:
    • Be permanently deleted from our records
    • Access, correction, edit or deletion of the data we hold about you
    • Portability of the data we hold about you
    • Opt-out of inclusion of your data in a specific project (newsletter, postal mailing etc.)

Please be assured we will treat your information with the utmost care and will never sell it to third parties for marketing purposes. Should you have any question, do not hesitate to contact us at This e-mail address is being protected from spambots. You need JavaScript enabled to view it .

Thank you,

IUIS Central Office

 
Subscribe to the IUIS Newsletter!

 

Dear colleagues,

As you already know, the International Union of Immunological Societies (IUIS) is an umbrella organization for many of the regional and national societies of immunology throughout the world. Every quarter, we issue a newsletter to share our major updates with immunologists and healthcare professionals from all over the world.


Why subscribe to the IUIS Newsletter?

Once every 3 months, you will find in your email inbox valuable proposals and relevant information such as:

If you wish to receive the IUIS Newsletter, please click SUBSCRIBE or scan the QR code below:

We hope to stay in touch and contribute to the advancement of global immunological science with your support.

Sincerely,

your IUIS Central Office

 
UA-110424807-1